RBD4059 injection clinical trials

A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of Repeated Subcutaneously Administered RBD4059 in Participants with Stable Coronary Artery Disease

This study is testing a new injection, RBD4059, for people with stable heart artery disease. We'll check if it's safe and how well the body handles it. We also want to see if it affects special blood markers linked to heart health.